SEC Form 4 · accession 0001144204-15-021797
Protea Biosciences Group, Inc. · PRGB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Antoline
Director · 10% Owner
Period of report
Apr 6, 2015
Accepted (ET)
Apr 8, 2015 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335103
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy)F1,F2 | $0.45 | Apr 6, 2015 | J | 1,630,000 | A | Apr 6, 2015 | Apr 6, 2020 | Common Stock | 1,630,000 | 1,630,000 | I |
Explanation of responses
- F1On April 1, 2015, the Issuer's Board of Directors authorized the issuance to Summit Resources, Inc. ("Summit") of a five-year warrant to purchase 1,630,000 shares of Common Stock, at an exercise price of $0.45 per share, in consideration of financial and other support previously provided by Summit to the Issuer.
- F2The Warrant is owned of record by Summit. The Reporting Person has voting and dispositive control over securities owned of record by Summit and may be deemed to beneficially own the Warrant held of record by Summit.